NPPB and cardiac hypertrophy: Compared to WKY rats, Nx-Ob-ZSF1 Vehicle rats also exhibited increased heart weight and plasma levels of the cardiac hypertrophy marker NT pro-BNP, which were both reduced by treatment with FG-2216 in Nx-Ob-ZSF1 rats.